<DOC>
	<DOCNO>NCT02473016</DOCNO>
	<brief_summary>A placebo-controlled , single-blind study evaluate safety preliminary efficacy nasal carbon dioxide symptomatic treatment classical trigeminal neuralgia .</brief_summary>
	<brief_title>Nasal Carbon Dioxide Symptomatic Treatment Classical Trigeminal Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Trigeminal Neuralgia</mesh_term>
	<criteria>Male female , 18 year age old . History classical trigeminal neuralgia without persistent background facial pain , secondary , define International Classification Headache Disorders ( ICHD ) , third edition , beta version ( ICHD3 beta , Cephalalgia 2013 ) . Diagnosis trigeminal neuralgia ( TN ) least 60 day prior enrollment . Experience pain score least 5 010 scale typical TN episode report subject . Note : Prior treatment pain score must 5 great VAS . History unilateral typical TN pain predominantly V2 branch trigeminal nerve . Absence significant structural lesion ( e.g. , tumor ) cause pain show least one neuroimaging study . On stable dose medication , include treatment TN prevention/prophylaxis , least 14 day prior baseline ( include , limited , verapamil , lithium , melatonin , anticonvulsant , systemic corticosteroid steroid injection , occipital nerve block , cranial extracranial nerve block , neurostimulation treatment ) . Note : Subjects allow use usual standard care acute/abortive treatment trigeminal neuralgia attack 60 minute initial dose , provide approve investigator . Capable complete diary . Able provide write Informed Consent . Are unable comply protocol requirement . Have recent alcohol drug abuse within 2 year prior study enrollment . Current major psychiatric disorder : suicidal ideation , bipolar , panic disorder , schizophrenic , psychosis . Subjects document clinically stable exhibit symptom relate psychiatric disorder eligible . History asthma ( mild intermittent ) . Have exist serious unstable systemic disease ( e.g. , severe emphysema , respiratory disease , heart disease , etc . ) preclude participation . Clinically significant nasal disorder ( deviate septum , presence polyp , evidence significant congestion , rhinitis , nasal abnormality ) prevents unrestricted breathe nostril . Currently anticoagulants diagnosis bleed disorder . Current diagnosis fibromyalgia , temporomandibular disorder ( TMD ) , odontogenic pain orofacial pain . Surgery treatment TN within 30 day prior screen . Note : Investigator must ensure patient surgery recovered experience side effect surgery treatment TN Females pregnant breastfeed and/or plan become pregnant breastfeed study participation within 30 day treatment . Participation previous study nasal CO2 . Participation another investigational drug study within 30 day prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Classical Trigeminal Neuralgia</keyword>
</DOC>